Zimmer Biomet Holdings Net Income 2006-2018 | ZBH

Zimmer Biomet Holdings annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Zimmer Biomet Holdings net income for the quarter ending December 31, 2018 was $-0.901B, a 173.18% decline year-over-year.
  • Zimmer Biomet Holdings net income for the twelve months ending December 31, 2018 was $-0.379B, a 120.91% decline year-over-year.
  • Zimmer Biomet Holdings annual net income for 2018 was $-0.379B, a 120.91% decline from 2017.
  • Zimmer Biomet Holdings annual net income for 2017 was $1.814B, a 492.94% increase from 2016.
  • Zimmer Biomet Holdings annual net income for 2016 was $0.306B, a 108.1% increase from 2015.
Zimmer Biomet Holdings Annual Net Income
(Millions of US $)
2018 $-379
2017 $1,814
2016 $306
2015 $147
2014 $720
2013 $780
2012 $755
2011 $761
2010 $597
2009 $717
2008 $849
2007 $773
2006 $835
2005 $733
Zimmer Biomet Holdings Quarterly Net Income
(Millions of US $)
Q4 2018 $-901
Q3 2018 $162
Q2 2018 $185
Q1 2018 $175
Q4 2017 $1,231
Q3 2017 $99
Q2 2017 $184
Q1 2017 $299
Q4 2016 $70
Q3 2016 $159
Q2 2016 $-31
Q1 2016 $109
Q4 2015 $127
Q3 2015 $22
Q2 2015 $-174
Q1 2015 $171
Q4 2014 $149
Q3 2014 $173
Q2 2014 $177
Q1 2014 $222
Q4 2013 $255
Q3 2013 $154
Q2 2013 $152
Q1 2013 $219
Q4 2012 $153
Q3 2012 $178
Q2 2012 $215
Q1 2012 $210
Q4 2011 $157
Q3 2011 $192
Q2 2011 $204
Q1 2011 $209
Q4 2010 $35
Q3 2010 $191
Q2 2010 $166
Q1 2010 $205
Q4 2009 $155
Q3 2009 $150
Q2 2009 $210
Q1 2009 $202
Q4 2008 $168
Q3 2008 $215
Q2 2008 $227
Q1 2008 $239
Q4 2007 $264
Q3 2007 $45
Q2 2007 $232
Q1 2007 $233
Q4 2006 $245
Q3 2006 $183
Q2 2006 $201
Q1 2006 $206
Q4 2005 $200
Q3 2005 $169
Q2 2005 $191
Q1 2005 $174
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $25.114B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.667B 26.06
Medtronic (MDT) Ireland $114.132B 16.69
Stryker (SYK) United States $69.756B 24.90
Boston Scientific (BSX) United States $49.905B 24.25
Baxter (BAX) United States $39.019B 25.03
Smith & Nephew SNATS (SNN) United Kingdom $16.786B 0.00
Canopy Growth (CGC) Canada $16.315B 0.00
ResMed (RMD) United States $14.544B 27.58
Aurora Cannabis (ACB) Canada $9.179B 64.71
Bio-Rad Laboratories (BIO) United States $8.795B 50.45
Perrigo (PRGO) Ireland $6.734B 10.92
Hill-Rom Holdings (HRC) United States $6.397B 19.79
GW Pharmaceuticals (GWPH) United Kingdom $4.994B 0.00
Insulet (PODD) United States $4.964B 1664.20
ICU Medical (ICUI) United States $4.636B 28.71
Haemonetics (HAE) United States $4.354B 38.62
Hutchison China MediTech (HCM) China $3.962B 0.00
Agios Pharmaceuticals (AGIO) United States $3.443B 0.00
Neogen (NEOG) United States $3.004B 48.85
NuVasive (NUVA) United States $2.967B 25.77
Quidel (QDEL) United States $2.487B 22.25
National Vision Holdings (EYE) United States $2.276B 44.77
Aphria (APHA) $1.957B 0.00
HEXO (HEXO) $1.474B 0.00
Phibro Animal Health (PAHC) United States $1.338B 19.24
VAREX IMAGING (VREX) United States $1.234B 24.16
Cardiovascular Systems (CSII) United States $1.212B 870.25
AtriCure (ATRC) United States $1.076B 0.00
Lantheus Holdings (LNTH) United States $0.957B 25.86
Omeros (OMER) United States $0.929B 0.00
PetIQ (PETQ) United States $0.865B 24.76
Cerus (CERS) United States $0.831B 0.00
MacroGenics (MGNX) United States $0.820B 0.00
NanoString Technologies (NSTG) United States $0.781B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.725B 24.66
TG Therapeutics (TGTX) United States $0.717B 0.00
Evolus (EOLS) United States $0.708B 0.00
OraSure Technologies (OSUR) United States $0.589B 25.68
Surmodics (SRDX) United States $0.584B 84.94
LeMaitre Vascular (LMAT) United States $0.555B 26.37
Meridian Bioscience (VIVO) United States $0.538B 16.02
Quanterix (QTRX) United States $0.515B 0.00
Insys Therapeutics (INSY) United States $0.332B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.329B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.19
BioLife Solutions (BLFS) United States $0.302B 124.61
Vapotherm (VAPO) United States $0.287B 0.00
Rockwell Medical (RMTI) United States $0.270B 0.00
Cytosorbents (CTSO) United States $0.228B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.172B 18.38
Bovie Medical (APYX) United States $0.140B 0.00
Chimerix (CMRX) United States $0.138B 0.00
Fonar (FONR) United States $0.128B 6.85
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Surface Oncology (SURF) United States $0.114B 0.00
United-Guardian (UG) United States $0.089B 20.32
Female Health (VERU) United States $0.088B 0.00
InfuSystems Holdings (INFU) United States $0.085B 0.00
Neurotrope (NTRP) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.86
GUARDION HEALTH (GHSI) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.024B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00